Headlines
-
Former WA pharmacist fined
Tuesday | Apr 18 2017AN UNREGISTERED former West Australian pharmacist has been fined $10,000 plus costs for holding himself out as a registered pharmacist while not being registered under the National Law.
-
FIP focusing on pharmacy roles
Thursday | Apr 13 2017THE International Pharmaceutical Federation (FIP) will highlight the huge diversity of healthcare roles played by pharmacists, with the theme of World Pharmacists Day 2017 to be "From research to healthcare, your pharmacist is at your service".
-
MA deal to cut prices again
Thursday | Apr 13 2017THE government and Medicines Australia are close to finalising a new five-year agreement which will see further cuts to the cost of some drugs in return for new listings and certainty for the sector.
-
NZ pharmacy software deal
Wednesday | Apr 12 2017NEW Zealand pharmacy software developer Toniq has been acquired by Dublin-based Clanwilliam Group, joining the company's portfolio of "best-of-breed" solutions in the UK, Ireland, Australia and New Zealand.
-
PPA urges Hunt on Review
Wednesday | Apr 12 2017PROFESSIONAL Pharmacists Australia has formally written to Health Minister Greg Hunt, urging him to continue to support the Review of Pharmacy Remuneration and Regulation which was initiated by his predecessor, Sussan Ley.
-
TGA launches codeine strategy
Tuesday | Apr 11 2017THE Therapeutic Goods Administration (TGA) has launched the first stage of communications to consumers about the rescheduling of codeine effective 01 Feb 2018, and is highlighting the importance of pharmacists in minimising harm from the medication.
-
Wages reform call – PSA
Monday | Apr 10 2017THE Pharmaceutical Society of Australia (PSA) has announced it is providing expert advice in support of a case to increase the award wage for pharmacists.
-
iNova bids below expectations
Friday | Apr 7 2017VALEANT Pharmaceuticals is reportedly "weighing its options" for iNova, its Australian subsidiary, after final bids in a sale process for the business (PD 23 Sep 2016) have come in much lower than the $1 billion expected.
-
FDA biosimilar guidance
Friday | Apr 7 2017WHILE Australia has taken on the relatively simplistic a-flagging policy for biosimilars using the in-situ pharmacy substitution approach used for small molecule generics (PD 04 Apr), the US Food and Drug Administration (FDA) is adopting a more complex approach, releasing its draft guidance on biosimilar interchageability for consultation, noting that there is "no single data package that will work for all proposed interchangeable products.
-
NZ reconsiders codeine
Friday | Apr 7 2017AUTHORITIES in New Zealand have confirmed that the country's Medicines Classification Committee will consider whether codeine based medicines should become prescription only.